This session will feature panelists from a covered entity (CE) and a manufacturer to offer perspective on CE considerations for the continuum of 340B Program oversight; from self-auditing best practices, to identification of root cause and scope of issues, to the self-disclosure and repayment process to resolve those issues.
More Information Coming Soon
Inform HRSA and manufacturers of 340B noncompliance and provide corrective action plan.
Self-assess your compliance to 340B requirements to prevent diversion and GPO violation.
Reference this sample PNP manual to support compliant 340B policy for Hemophilia Treatment Center grantees.
Find out more about what we do and how we can help you.